Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01NSM
|
|||
| Former ID |
DNCL002200
|
|||
| Drug Name |
TST-10088
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [1] | |
| Company |
Cangene Winnipeg, Canada
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Ribosome (hRBS) | Target Info | Immunomodulator (Immunostimulant) | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics-Oct 22-26, 2007, San Francisco, CA. | |||
| REF 2 | Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2009 Nov;31(9):597-633. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.